Who's missing out? The truth behind food allergy treatment approvals
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
Traditional data aggregators are not enough The pharmaceutical industry is hitting a wall. Data...
Open claims and closed payer claims data are essential for understanding the status and activities...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs) pose a significant health risk due to their potential to cause life-threatening reactions, such as anaphylaxis. These conditions represent a critical area...